---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-009186"
form_type: "8-K"
ticker: "BGLC"
cik: "0001737523"
company_name: "BioNexus Gene Lab Corp"
filed_at: "2025-12-23T23:59:59+00:00"
generated_at: "2026-05-16T12:16:32.093336+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Chemrex subsidiary governance shake-up: four directors resign; new chairman appointed

## Summary
- Four Chemrex officers/directors (Too Kam Tham, Liong Tai Tan, Wei Foong Lim, Kuan Yew Tan) resigned on Dec 19, 2025.
- Matthew L. Barsing appointed as chairman of Chemrex board; brings tech and public-sector experience.
- Chemrex governance review ongoing, assessing historical compliance, governance, and operational matters.
- Chemrex exploring potential CDMO expansion as part of strategic shift toward biotech development.

## SEC filing metadata
- accession: 0001477932-25-009186
- form_type: 8-K
- ticker: BGLC
- cik: 0001737523
- company_name: BioNexus Gene Lab Corp
- filed_at: 2025-12-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737523/000147793225009186/0001477932-25-009186-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737523/000147793225009186/bglc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-009186
- JSON: https://secwatch.observer/filing/0001477932-25-009186.json
- Plain text: https://secwatch.observer/filing/0001477932-25-009186.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.